Electrophysiology Unit, De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.
Clinical Cardiology Unit, De Gasperis Cardio Center, Niguarda Hospital, 20162 Milan, Italy.
Medicina (Kaunas). 2024 May 16;60(5):819. doi: 10.3390/medicina60050819.
Over the past decade, remote monitoring (RM) has become an increasingly popular way to improve healthcare and health outcomes. Modern cardiac implantable electronic devices (CIEDs) are capable of recording an increasing amount of data related to CIED function, arrhythmias, physiological status and hemodynamic parameters, providing in-depth and updated information on patient cardiovascular function. The extensive use of RM for patients with CIED allows for early diagnosis and rapid assessment of relevant issues, both clinical and technical, as well as replacing outpatient follow-up improving overall management without compromise safety. This approach is recommended by current guidelines for all eligible patients affected by different chronic cardiac conditions including either brady- and tachy-arrhythmias and heart failure. Beyond to clinical advantages, RM has demonstrated cost-effectiveness and is associated with elevated levels of patient satisfaction. Future perspectives include improving security, interoperability and diagnostic power as well as to engage patients with digital health technology. This review aims to update existing data concerning clinical outcomes in patients managed with RM in the wide spectrum of cardiac arrhythmias and Hear Failure (HF), disclosing also about safety, effectiveness, patient satisfaction and cost-saving.
在过去的十年中，远程监测 (RM) 已成为改善医疗保健和健康结果的一种日益流行的方法。现代心脏植入式电子设备 (CIED) 能够记录与 CIED 功能、心律失常、生理状态和血液动力学参数相关的越来越多的数据，提供关于患者心血管功能的深入和最新信息。广泛使用 RM 监测 CIED 患者可实现早期诊断和快速评估相关问题，包括临床和技术问题，并可替代门诊随访，改善整体管理，同时不影响安全性。当前的指南建议所有符合条件的患者都采用这种方法，这些患者患有不同的慢性心脏疾病，包括缓慢性和快速性心律失常以及心力衰竭。除了临床优势外，RM 还具有成本效益，并与患者满意度的提高有关。未来的展望包括提高安全性、互操作性和诊断能力，并利用数字健康技术让患者参与其中。这篇综述旨在更新有关在广泛的心律失常和心力衰竭 (HF) 患者中使用 RM 管理的临床结果的现有数据，同时还披露安全性、有效性、患者满意度和节省成本的情况。
